blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2167480

EP2167480 - CATIONIC LIPIDS COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.01.2017
Database last updated on 09.09.2024
Most recent event   Tooltip06.01.2017Application deemed to be withdrawnpublished on 08.02.2017  [2017/06]
Applicant(s)For all designated states
VICAL INCORPORATED
10390 Pacific Center Court
San Diego, California 92121-4340 / US
[2010/13]
Inventor(s)01 / HARTIKKA, Jukka
3920 Brooke Court
La Mesa, California 91941-7894 / US
02 / SULLIVAN, Sean, M.
7638 Heatherly Lane
San Diego, California 92130 / US
03 / ENAS, Joel, D.
210 Sky Country Court
Fallbrook, California 92028 / US
04 / ROLLAND, Alain
10696 Edenoaks Street
San Diego, California 92131 / US
 [2010/13]
Representative(s)Roques, Sarah Elizabeth
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
[N/P]
Former [2010/13]Roques, Sarah Elizabeth
J.A. Kemp & Co. 14 South Square Gray's Inn
GB-London WC1R 5JJ / GB
Application number, filing date08769711.623.05.2008
[2010/13]
WO2008US64786
Priority number, dateUS20070939702P23.05.2007         Original published format: US 939702 P
US20080044338P11.04.2008         Original published format: US 44338 P
[2016/11]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008148057
Date:04.12.2008
Language:EN
[2008/49]
Type: A2 Application without search report 
No.:EP2167480
Date:31.03.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 04.12.2008 takes the place of the publication of the European patent application.
[2010/13]
Search report(s)International search report - published on:EP19.02.2009
ClassificationIPC:C07D295/13, C07C217/28, A61K39/39, A61K47/18, A61P31/04, A61P31/12, A61P35/00, C07D211/46
[2010/13]
CPC:
C07C217/28 (EP,US); C12N15/88 (US); A61K39/39 (US);
A61P31/04 (EP); A61P31/12 (EP); A61P35/00 (EP);
A61P37/02 (EP); A61P37/04 (EP); C07D211/44 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/13]
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERBESSERUNG DER IMMUNREAKTIONEN AUF IMPFSTOFFE[2010/13]
English:CATIONIC LIPIDS COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES[2010/13]
French:COMPOSITIONS ET PROCÉDÉS POUR AMÉLIORER LA RÉPONSE IMMUNITAIRE À DES VACCINS[2010/13]
Entry into regional phase22.12.2009National basic fee paid 
22.12.2009Designation fee(s) paid 
22.12.2009Examination fee paid 
Examination procedure22.12.2009Examination requested  [2010/13]
02.03.2010Amendment by applicant (claims and/or description)
30.06.2010Despatch of a communication from the examining division (Time limit: M06)
06.01.2011Reply to a communication from the examining division
01.03.2011Despatch of a communication from the examining division (Time limit: M06)
09.09.2011Reply to a communication from the examining division
12.01.2012Despatch of a communication from the examining division (Time limit: M06)
19.07.2012Reply to a communication from the examining division
30.07.2012Despatch of a communication from the examining division (Time limit: M06)
06.02.2013Reply to a communication from the examining division
26.02.2013Despatch of a communication from the examining division (Time limit: M06)
23.07.2013Reply to a communication from the examining division
19.09.2013Despatch of a communication from the examining division (Time limit: M06)
27.02.2014Reply to a communication from the examining division
18.09.2014Despatch of a communication from the examining division (Time limit: M04)
22.01.2015Reply to a communication from the examining division
20.05.2015Despatch of a communication from the examining division (Time limit: M04)
17.09.2015Reply to a communication from the examining division
31.03.2016Communication of intention to grant the patent
11.08.2016Application deemed to be withdrawn, date of legal effect  [2017/06]
16.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2017/06]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  30.06.2010
Fees paidRenewal fee
31.03.2010Renewal fee patent year 03
10.05.2011Renewal fee patent year 04
21.03.2012Renewal fee patent year 05
26.03.2013Renewal fee patent year 06
26.03.2014Renewal fee patent year 07
07.05.2015Renewal fee patent year 08
Penalty fee
Additional fee for renewal fee
31.05.201609   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO9405624  (LIFE TECHNOLOGIES INC [US]) [X] 1 * claims 1,3,4,... *;
 [X]WO9814439  (VICAL INC [US], et al) [X] 42-67,69-84 * figures 1-7; claims 1-37 *;
 [X]US6670332  (WHEELER CARL J [US]) [X] 1-8,15-24,28-37 * the whole document * * claims 51,52 * * example 12 *;
 [X]WO2004105697  (MOLECULAR TRANSFER INC [US], et al) [X] 1 * compound 13 *;
 [XD]US7105574  (WHEELER CARL J [US]) [XD] 1-7,15-26,28-41,83-85 * columns 3,4,6; figures 2-4 *;
 [X]  - FERRARI MARILYN E ET AL, "Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes.", NUCLEIC ACIDS RESEARCH 15 APR 2002, (20020415), vol. 30, no. 8, ISSN 1362-4962, pages 1808 - 1816, XP002497337 [X] 1-7,15-26 * the whole document *

DOI:   http://dx.doi.org/10.1093/nar/30.8.1808
 [X]  - WHEELER C J ET AL, "CONVERTING AN ALCOHOL TO AN AMINE IN A CATIONIC LIPID DRAMATICALLY ALTERS TO CO-LIPID REQUIREMENT, CELLULAR TRANSFECTION ACTIVITY AND THE ULTRASTRUCTURE OF DNA-CYTOFECTIN COMPLEXES", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, (19960101), vol. 1280, no. 1, ISSN 0006-3002, pages 1 - 11, XP002035803 [X] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1016/0005-2736(95)00256-1
 [XD]  - WHEELER C J ET AL, "A NOVEL CATIONIC LIPID GREATLY ENHANCES PLASMID DNA DELIVERY AND EXPRESSION IN MOUSE LUNG", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC.; US, (19961001), vol. 93, ISSN 0027-8424, pages 11454 - 11459, XP000946063 [XD] 1,2 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.93.21.11454
 [X]  - MENGER F M ET AL, "Lipid-catalyzed transport of copper(II) through liquid membranes", JOURNAL OF ORGANIC CHEMISTRY, (1993), vol. 58, no. 7, ISSN 0022-3263, pages 1909 - 1916, XP002497607 [X] 1 * compound 2 *

DOI:   http://dx.doi.org/10.1021/jo00059a050
 [X]  - MANTHORPE M ET AL, "Plasmid vaccines and therapeutics: from design to applications", ADVANCES IN BIOCHEMICAL ENGINEERING, BIOTECHNOLOGY, SPRINGER, BERLIN, DE, (20050101), vol. 99, ISSN 0724-6145, pages 41 - 92, XP008097068 [X] 83-85 * page 44 * * page 68 - page 72; table 6 *

DOI:   http://dx.doi.org/10.1007/10_003
 [A]  - NICULESCU-DUVAZ DAN ET AL, "Structure-activity relationship in cationic lipid mediated gene transfection.", CURRENT MEDICINAL CHEMISTRY JUL 2003, (200307), vol. 10, no. 14, ISSN 0929-8673, pages 1233 - 1261, XP008099342 [A] * the whole document *

DOI:   http://dx.doi.org/10.2174/0929867033457476
 [A]  - KARMALI PRIYA PRAKASH ET AL, "Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questions, and future promises.", MEDICINAL RESEARCH REVIEWS SEP 2007, (20061004), vol. 27, no. 5, ISSN 0198-6325, pages 696 - 722, XP002506974

DOI:   http://dx.doi.org/10.1002/MED.20090
 [A]  - MAJETI BHARAT KUMAR ET AL, "Enhanced intravenous transgene expression in mouse lung using cyclic-head cationic lipids.", CHEMISTRY & BIOLOGY APR 2004, (200404), vol. 11, no. 4, ISSN 1074-5521, pages 427 - 437, XP002506975

DOI:   http://dx.doi.org/10.1016/J.CHEMBIOL.2004.03.015
by applicantUS7105574
    - FELGNER, SCIENTIFIC AMERICAN, (1997), vol. 276, no. 6, pages 102 - 106
    - BINS; A. D.; A. JORRITSMA ET AL., "A ranid and notent DNA vaccination strategy defined by in vivo monitoring of antigen expression", NAT MED, (2005), vol. 11, no. 8, pages 899 - 904
    - HARTIKKA, J.; V. BOZOUKOVA ET AL., "Vaxfectin enhances the humoral immune response to plasmid DNA-encoded antigens", VACCINE, (2001), vol. 19, no. 15-16, pages 1911 - 23
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.